Rayno Life Science Portfolio Notes- Q3 Earnings in Two weeks
The Rayno Life Science Portfolio is up 20% and later this month we will see important earnings reports from tools and diagnostics companies. Life Science stocks are outperforming the NASDAQ and S&P in 2010. Exact Sciences(EXAS) $8.89 was a high flier for Q3 with the stock tripling from the $3 level. Pre-clinical validation data on [...]
